Overview

Simvastatin Metabolism as a Test for CD Activity (IRB 15-007568]

Status:
Completed
Trial end date:
2019-02-01
Target enrollment:
Participant gender:
Summary
To study the correlation between simvastatin metabolism by the enterocyte and the histologic state of the intestine in treated celiac disease.
Phase:
Early Phase 1
Details
Lead Sponsor:
Immunogenics, LLC
Mayo Clinic
Treatments:
Simvastatin